NCT00001209View on ClinicalTrials.gov

A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

October 31, 1986

Study Completion Date

August 31, 2000

Conditions

Neuroectodermal Tumor, PrimitiveNeuroepitheliomaOsteosarcomaSarcomaSarcoma, Ewing's

Interventions

DRUG

vincristine, adriamycin and cytoxan, alternating with ifosfamide VP-16

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00001209 - A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors | Biotech Hunter | Biotech Hunter